Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.
AUTOR(ES)
Caruso, I
RESUMO
Thirty rheumatoid patients with persistent knee effusion were treated intra-articularly with rifamycin SV, 500 mg weekly, or with saline solution, 10 ml, in a double-blind study. A complete disappearance of effusion and an impressive clinical improvement was observed in the patients on rifamycin. The synovial fluid and membrane underwent some changes. In 2 patients the rifamycin caused a painful local reaction. After a follow-up of 5 years only one patient has experienced effusion relapse, 5 months after the termination of rifamycin SV treatment. The patients on saline showed no significant change. On the basis of the results obtained from the monoarthritis experimental model and from clinical trials it is tempting to consider that rifamycin has an antimitotic effect, impeding the synthesis of RNA and DNA polymerases in immunocompetent cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000916Documentos Relacionados
- Intra-articular rheumatoid nodules and triggering of the knee joint.
- Intra-articular pressure in rheumatoid arthritis of the knee. II. Effect of intra-articular pressure on blood circulation to the synovium.
- Intra-articular thiotepa in rheumatoid arthritis.
- Intra-articular urokinase in rheumatoid arthritis.
- Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis.